Pfizer and BioNTech announced phase 3 study of COVID-19 vaccine candidate met all efficacy endpoints
On Nov. 18, 2020, Pfizer and BioNTech announced that, after conducting the final efficacy analysis in their ongoing…
On Nov. 18, 2020, Pfizer and BioNTech announced that, after conducting the final efficacy analysis in their ongoing…
On Nov. 16, 2020, BioNTech and Shanghai Fosun Pharmaceutica announced that the China National Medical Products Administration had…
On Nov. 11, 2020, Pfizer and BioNTech announced that they had reached an agreement with the European Commission…
On Nov. 9, 2020, Pfizer and BioNTech announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 had demonstrated evidence…
On Oct. 14, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from the Phase 1 portion of…
On Oct. 9, 2020, Pfizer and BioNTech announced the initiation of a rolling submission to Health Canada for…
On Oct. 7, 2020, Rentschler Biopharma announced an agreement to serve as CDMO partner for BioNTech. As an…
On Oct. 6, 2020, Pfizer and BioNTech announced initiation of a rolling submission to the European Medicines Agency…
On Sept. 30, 2020, researchers at the Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary…
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
On Sept. 29, 2020, In a new Letter, published in PNAS, researchers at La Jolla Institute for Immunology…
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesメ four investigational vaccine candidates from…
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Dec. 31, 2019, Ege T. Kavalali, Ph.D., professor and acting chair of the Department of Pharmacology in…
On Nov. 14, 2012, scientists from the U.S., United Kingdom and Germany announced they had completed the first…
On Feb. 7, 2012, The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, completed the genome sequence…
On Oct. 13, 2011, an international team, led by researchers at McMaster University and the University of Tubingen…
On Jan. 21, 2009, the Rotary International, the Bill & Melinda Gates Foundation, and the British and German…
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
In 2000, Eli Lilly and Takeda Chemical launched Actos, an oral anti diabetes agent. In 2005, a PROactive…
In 1989, the Administrative Supreme Court of the state of Hesse, West Germany, blocks the multinational chemical company…
In 1982, the first major DNA sequence databases were established in the U.S. (GenBank) and Germany. GenBank ®…
On Dec. 25, 1956, the first Thalidomide birth occurred in Germany. Thalidomide, a new sleeping pill developed by…
In 1945, the American Chemical Society awarded the Priestley Medal to Ian Heilbron, “to recognize distinguished services to…
In 1944, the the American Chemical Society awarded the Priestley Medal to James B. Conant “to recognize distinguished…
In 1942, the first phage electron micrographs (EM) were published in 1940 in Germany and proved the particulate…
In 1917, the University of Iowa College of Pharmacy secretly produced bootleg aspirin after the war in Europe…
On Aug. 10, 1897, German chemist Felix Hoffmann searching for something to relieve his father’s arthritis synthesized acetylsalicylic…
In 1896, Almroth Edward Wright, Richard Pfeiffer and Wilhelm Kolle developed the first typhoid vaccine. It was a…
In 1894, German chemist Felix Hoffmann, one of the inventors of Aspirin, joined “Farbenfabriken vorm. Friedr. Bayer &…